Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...

Detroit resident Heidi Penix started a garden while simultaneously learning of a cancer diagnosis. “It’s a constant process of learning what it takes to keep things alive,” she says.

Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.

Adaptimmune Therapeutics’ lete-cel data achieves primary endpoint in pivotal phase 2 IGNYTE-ESO trial: Philadelphia Friday, November 15, 2024, 13:00 Hrs [IST] Adaptimmune Therap ...

Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical ...

OBODENCE™ and XBRYK™ recommended for approval by the European Medicines Agency for all indications referencing Prolia and Xgeva, respectively INCHEON, South Korea, Nov. 15, 2024 (GLOBE NEWSWIRE) -- ...

Regulators are reviewing what could become a multi-billion-dollar drug.

Gilead Sciences, Inc. today announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% (30 out of 37) of participants with primary biliary ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

More people living in rural areas of the United States are dying from heart attacks, strokes and other cardiovascular ...

Emmy-winning talk show host and comedian Conan O'Brien has been tapped to emcee the 97th Academy Awards, set for March 2, the academy announced Friday.